Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi Sankyo Forecasts Fall for Fiscal 2008 Due To Overseas Investments, R&D Growth

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Profits for fiscal 2007 were lower than expected and earnings are to decline for fiscal 2008 "under the challenging environment such as the National Health Insurance drug price revisions and the stronger yen," said Takashi Shoda, president and CEO of Daiichi Sankyo at its headquarters in Tokyo, May 14. Shoda also cited the company's heavy investment in overseas facilities and its R&D growth as factors for the negative forecast
Advertisement

Related Content

Daiichi Sankyo To Expand European Presence With Acquisition Of 130 Merck KGaA Medical Reps
Daiichi Sankyo To Expand European Presence With Acquisition Of 130 Merck KGaA Medical Reps
First Biosimilar Reviews Raise Questions About Differences In Asia
Japan To Cut Drug Prices in April
Japan To Cut Drug Prices in April
Astellas, Daiichi Move Ahead With Factor Xa Programs
Advertisement
UsernamePublicRestriction

Register

SC068526

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel